Telles advised NORS Group on the sale of Auto Sueco II Automóveis, player in the automotive retail market in Portugal, to CARCLASSE and JOP
Tags :Telles
Telles has advised the shareholders of Endiprev, a group of companies that is a global benchmark in wind energy services, on the sale process to the Danish company Muehlhan Wind Service (MWS), one of the
TELLES has bolstered its tax department with the addition of Vasco Simões and Mariana Leite da Silva, under the leadership of Miguel Torres, partner and chairman of the law firm. Vasco Simões brings
Telles has advised 100% of the sale of Portugal’s leading dairy group, consisting of Sequeira & Sequeira (S&S), Lacticínios do Paiva, S.A. (Portugal), Lactopaiva Cabo Verde and Lactopaiva Moçambique, to
Telles is providing legal advice to LIPOR – Association of Municipalities for the Sustainable Management of Waste in Greater Porto – on the creation of the Renewable Energy Community. This ground-breaking initiative in Portugal aims to use
Telles has anounced that Francisco Espregueira Mendes will be the firm’s new managing partner, replacing Miguel Torres. Mendes will commence a new mandate for the three-year period 2024-2026. He will be supported by a
With more than 15 years of experience, Matilde Cortez Pinto has joined the litigation and arbitration team, led by partner André Navarro de Noronha. The new senior associate at Telles is recognised for her expertise in
Telles has advised Beta Capital, a management company for collective investment schemes, on the creation and launch of the Sogrape Ventures venture capital fund. The Sogrape Ventures Fund is designed to invest in disruptive start-ups
Telles’ tax team, led by partner Miguel Torres, recently won an important case before the CJEU that could have a significant impact on Portuguese case law. The case concerned an action brought before the Administrative
Telles has advised the shareholders of BlueClinical on the integration of BlueClinical into Astrum, a pan-European group recently created by Henko Capital Partners, providing high quality CRO (Clinic Research Organisation) services to the pharmaceutical, biotechnology,
